Research examines interventions in treating African-Americans with substance abuse

February 19, 2013 in Psychology & Psychiatry

New research out of the University of Cincinnati reveals a relatively rare look into the success of substance abuse treatment programs for African-Americans. Researchers report that self-motivation could be an important consideration into deciding on the most effective treatment strategy. The study led by Ann Kathleen Burlew, a UC professor of psychology, and LaTrice Montgomery, a UC assistant professor of human services, is published online this week in Psychology of Addictive Behaviors.

Specifically among African-Americans, the study investigated the effectiveness of Motivational Enhancement Therapy (MET) compared with the standard treatment, Counseling as Usual (CAU).

Motivation Enhancement Therapy – which involves expressing empathy, setting goals, avoiding argumentation and supporting self-efficacy – is designed to address the ambivalence surrounding , whether abusers are at the stage where they're ready to live a substance-free life or whether they are still denying the need for any treatment.

The study examined the relation of treatment type and the motivation for treatment to the outcomes of the participants. The researchers found that for participants in Motivational Enhancement Therapy (MET), the substance abusers who were highly motivated to change reported fewer days of substance abuse per week than participants in Counseling As Usual (CAU) programs. However, among the lower-motivated participants, the Counseling As Usual (CAU) participants reported fewer days of substance abuse over time than participants in Motivational Enhancement Therapy (MET).

The researchers report that the study contributes to the public health need for more empirical evidence on effective substance abuse treatments for African-Americans. The researchers reported finding only two previous readiness-to-change (RTC) studies with African-Americans, completed two decades ago.

The study is a secondary analysis of a clinical trial by the National Clinical Trials Network. The findings focused on 194 African-Americans in five community treatment programs over a 16-week period. Their average age was 37. Approximately one-fourth of the African-American population studied (24.7 percent) was female. The self-reported substance abuse ranged from alcohol (26.3 percent) to cocaine (25.8 percent), marijuana (18 percent), two or more drugs (24.2 percent) or other drugs (5.6 percent) as their primary drug of choice.

The UC research was supported by a grant from the National Institute of Drug Abuse.

Additional researchers on the study are Andrzej Kosinski, associate professor of biostatistics and bioinformatics, Duke University School of Medicine; and Alyssa Forcehimes, assistant professor of psychiatry, University of New Mexico.

More information: psycnet.apa.org/in… e=1&dbTab=pa

Journal reference: Psychology of Addictive Behaviors search and more info website

Provided by University of Cincinnati search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Weather worries can threaten a child's mental health

(HealthDay)—The monstrous tornado that devastated Moore, Okla., on Monday, killing dozens of adults and children, is a stunning example of violent weather that can affect a child's mental well-being.

Psychology & Psychiatry created 12 hours ago | popularity not rated yet | comments 0

Teens exposed to schoolmate's death by suicide much more likely to consider or attempt suicide

Youth who had a schoolmate die by suicide are significantly more likely to consider or attempt suicide, according to a study in published in CMAJ (Canadian Medical Association Journal). This effect can last 2 years or mo ...

Psychology & Psychiatry created 15 hours ago | popularity not rated yet | comments 0

Genetic predictors of postpartum depression uncovered

Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.

Psychology & Psychiatry created May 21, 2013 | popularity not rated yet | comments 0 | with audio podcast

Mediterranean diet seems to boost ageing brain power

A Mediterranean diet with added extra virgin olive oil or mixed nuts seems to improve the brain power of older people better than advising them to follow a low-fat diet, indicates research published online in the Journal of ...

Psychology & Psychiatry created May 20, 2013 | popularity 3.5 / 5 (2) | comments 2

The incidence of eating disorders is increasing in the UK

More people are being diagnosed with eating disorders every year and the most common type is not either of the two most well known—bulimia or anorexia—but eating disorders not otherwise specified (eating disorders that ...

Psychology & Psychiatry created May 20, 2013 | popularity not rated yet | comments 0


Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens

Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...